UGT2B7 and hepatocellular carcinoma: UDP-glucuronosyltransferase 2B7 (UGT2B7) has been identified as a subtype classification biomarker for hepatocellular adenoma [35] and one as a gene signature that can accurately predict microvascular invasion in HCC [36], indicating its importance in liver cancer.